AR134641A1 - Formas salinas de un modulador del receptor glp-1 - Google Patents

Formas salinas de un modulador del receptor glp-1

Info

Publication number
AR134641A1
AR134641A1 ARP240103420A ARP240103420A AR134641A1 AR 134641 A1 AR134641 A1 AR 134641A1 AR P240103420 A ARP240103420 A AR P240103420A AR P240103420 A ARP240103420 A AR P240103420A AR 134641 A1 AR134641 A1 AR 134641A1
Authority
AR
Argentina
Prior art keywords
compound
salt
glp
salts
description
Prior art date
Application number
ARP240103420A
Other languages
English (en)
Spanish (es)
Inventor
Xiaoyang Wang
Xiaoyu Ma
Yanan Wu
Original Assignee
Carmot Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmot Therapeutics Inc filed Critical Carmot Therapeutics Inc
Publication of AR134641A1 publication Critical patent/AR134641A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP240103420A 2023-12-11 2024-12-11 Formas salinas de un modulador del receptor glp-1 AR134641A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2023137926 2023-12-11

Publications (1)

Publication Number Publication Date
AR134641A1 true AR134641A1 (es) 2026-02-04

Family

ID=94083674

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240103420A AR134641A1 (es) 2023-12-11 2024-12-11 Formas salinas de un modulador del receptor glp-1

Country Status (3)

Country Link
AR (1) AR134641A1 (fr)
TW (1) TW202527936A (fr)
WO (1) WO2025128564A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023008854A (es) 2021-01-28 2023-10-17 Carmot Therapeutics Inc Agonistas del receptor acoplado a proteinas g (gpcr), composiciones farmaceuticas que los comprenden y metodos para su uso.
WO2023182869A1 (fr) * 2022-03-25 2023-09-28 Ildong Pharmaceutical Co., Ltd. Nouveau sel de composé agoniste du récepteur glp-1, son procédé de préparation et composition pharmaceutique le comprenant
CN117362282B (zh) * 2022-07-07 2026-04-21 杭州德睿智药科技有限公司 Glp-1r激动剂的盐及其制备方法和应用

Also Published As

Publication number Publication date
WO2025128564A1 (fr) 2025-06-19
TW202527936A (zh) 2025-07-16

Similar Documents

Publication Publication Date Title
CL2022003360A1 (es) Benzofurano, benzopirrol, benzotiofeno sustituidos y otros inhibidores del complemento estructuralmente relacionados (divisional de la solicitud 202002578)
AR128931A1 (es) Inhibidores del factor b del complemento y usos de los mismos
CR20220363A (es) Compuestos tricíclicos sustituidos
CL2025002456A1 (es) Agonistas heterocíclicos de glp-1
MX2021011606A (es) Compuestos dirigidos a prmt5.
CL2024000861A1 (es) Ácidos carboxílicos de benzimidazol como agonistas de glp-1r
PA8530401A1 (es) Agonistas del receptor b3 adrenergico y usos de los mismos
AR128717A1 (es) Formas sólidas, sales y procesos de preparación de un inhibidor de cdk2
CO2021007613A2 (es) Formas cristalinas y formas de sal de un inhibidor de cinasa
CO2024003723A2 (es) Compuestos de imidazopiridazina inhibidores de il-17
CO2021017343A2 (es) Formas de sales cristalinas de un inhibidor de cinasas
CO6241155A2 (es) [4-(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2hquinazolina-3-ilo)-fenilo]-5-cloro-tiofeno-2-ilo-sales de sulfonilurea y las formas y metodos relacionados con el mismo
CO2025003099A2 (es) Compuestos para el tratamiento del cáncer
AR075097A1 (es) Sales y formas polimorficas cristalinas de [4-(6-fluoro-7-metilamino-2,4-dioxo-1,4-dihidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonil urea, composiciones farmaceuticas que las contiene, metodo para prepararlas y uso de las mismas en el tratamiento de enfermedades cardiovasculares asocia
CO2021011042A2 (es) Sales de sulcardina
ECSP21093897A (es) Compuestos y métodos de uso de los mismos como agentes antibacterianos
CL2024002500A1 (es) Inhibidores de proteínas de unión a emopamilo y usos de estos
AR119317A1 (es) Un derivado de tetrahidroisoquinolina sustituido como modulador alostérico positivo de d1
AR132497A1 (es) Combinación de obicetrapib amorfo e inhibidor de sglt2
AR115921A1 (es) Ácido isolitocólico o ácido isoalolitocólico y derivados deuterados de los mismos para prevenir y tratar enfermedades asociadas a clostridium difficile
AR128206A1 (es) Nuevos derivados de aminoácidos no codificados y su uso como herbicidas
AR134640A1 (es) Formas cristalinas de un modulador del receptor glp-1
MX2022015532A (es) Inhibidores selectivos de hdac6 y usos de los mismos.
TW201318629A (zh) 以組合透明質酸及黃素腺嘌呤二核苷酸為特徵的角膜上皮細胞死亡抑制劑
MX2024014106A (es) Composiciones para prevenir o tratar la fibrosis pulmonar idiopatica (ipf)